Tevogen Ebitda from 2010 to 2024

TVGNW Stock   0.05  0  5.63%   
Tevogen Bio EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA is likely to outpace its year average in 2024. During the period from 2010 to 2024, Tevogen Bio EBITDA regression line of quarterly data had r-squared of  0.01 and coefficient of variation of (426.07). View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
188.7 K
Current Value
198.1 K
Quarterly Volatility
258.8 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tevogen Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tevogen Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 160.5 K, Interest Expense of 227.9 K or Selling General Administrative of 1.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Tevogen financial statements analysis is a perfect complement when working with Tevogen Bio Valuation or Volatility modules.
  
Check out the analysis of Tevogen Bio Correlation against competitors.

Latest Tevogen Bio's Ebitda Growth Pattern

Below is the plot of the Ebitda of Tevogen Bio Holdings over the last few years. It is Tevogen Bio's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tevogen Bio's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Very volatile
   Ebitda   
       Timeline  

Tevogen Ebitda Regression Statistics

Arithmetic Mean(60,745)
Coefficient Of Variation(426.07)
Mean Deviation118,978
Median(28,745)
Standard Deviation258,816
Sample Variance67B
Range1.2M
R-Value(0.11)
Mean Square Error71.3B
R-Squared0.01
Significance0.71
Slope(6,174)
Total Sum of Squares937.8B

Tevogen Ebitda History

2024198.1 K
2023188.7 K
2022-953.1 K

About Tevogen Bio Financial Statements

Tevogen Bio investors use historical fundamental indicators, such as Tevogen Bio's Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tevogen Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA188.7 K198.1 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tevogen Stock Analysis

When running Tevogen Bio's price analysis, check to measure Tevogen Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tevogen Bio is operating at the current time. Most of Tevogen Bio's value examination focuses on studying past and present price action to predict the probability of Tevogen Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tevogen Bio's price. Additionally, you may evaluate how the addition of Tevogen Bio to your portfolios can decrease your overall portfolio volatility.